James C. Mullen joined Biogen Inc. in 1989.
(Pat Greenhouse/ Globe Staff/ File 2006)
CEO of Biogen Idec to retire
Departure unrelated to Icahn, spokesman says
James C. Mullen joined Biogen Inc. in 1989.
(Pat Greenhouse/ Globe Staff/ File 2006)
James C. Mullen, who battled with billionaire investor Carl Icahn over the direction and future of Biogen Idec Inc. , will retire as chief executive of the Cambridge biotechnology firm in June, the company announced yesterday. (Full article: 567 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
